Information:
Fel:
ID
16012
Beskrivning
Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193011
Länk
https://clinicaltrials.gov/show/NCT00193011
Nyckelord
Versioner (2)
- 2016-05-02 2016-05-02 -
- 2016-06-26 2016-06-26 -
Uppladdad den
26 juni 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Breast Cancer NCT00193011
Eligibility Breast Cancer NCT00193011
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00193011
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Inclusion criteria
Item
to be included in this study, you must meet the following criteria:
boolean
female patients with adenocarcinoma of the breast
Item
female patients with adenocarcinoma of the breast confirmed by biopsy
boolean
C0079399 (UMLS CUI [1,1])
C0019638 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
C0019638 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
age
Item
age 65 or older
boolean
C0001779 (UMLS CUI [1])
significant medical illness
Item
under age 65 must have significant medical illness, or general frailty
boolean
C0205082 (UMLS CUI [1,1])
C0221423 (UMLS CUI [1,2])
C0424594 (UMLS CUI [2])
C0221423 (UMLS CUI [1,2])
C0424594 (UMLS CUI [2])
bone marrow, liver or kidney function
Item
adequate bone marrow, liver or kidney function
boolean
C0005953 (UMLS CUI [1,1])
C0232741 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
C0232741 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
cardiac function
Item
normal heart function
boolean
C0232164 (UMLS CUI [1])
time since surgery
Item
less than 84 days from mastectomy/lumpectomy or axillary dissection
boolean
C1272706 (UMLS CUI [1,1])
C3714726 (UMLS CUI [1,2])
C3714726 (UMLS CUI [1,2])
informed consent
Item
signed consent obtained prior to initiation of any study procedures
boolean
C0021430 (UMLS CUI [1])
Exclusion Criteria
Item
you cannot participate in this study if any of the following apply to you:
boolean
Neoadjuvant Therapy
Item
received neo-adjuvant therapy
boolean
C0600558 (UMLS CUI [1])
locally advanced tumor
Item
primary tumor is locally advanced at diagnosis
boolean
C0205179 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,2])
prior chemotherapy
Item
received prior chemotherapy within five years
boolean
C1514457 (UMLS CUI [1])
previous radiation therapy
Item
received previous radiation therapy within 5 years
boolean
C1522449 (UMLS CUI [1])
Peripheral Neuropathy
Item
peripheral neuropathy
boolean
C0031117 (UMLS CUI [1])
ID.15
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean